financetom
Business
financetom
/
Business
/
Britannia Industries Q1FY22 earnings preview: Street expects 7.5% decline in revenues
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Britannia Industries Q1FY22 earnings preview: Street expects 7.5% decline in revenues
Jul 29, 2021 7:26 AM

Britannia Industries will report its Q1FY22 results today and this time around biscuits are likely to lose their crunch and that is because of a high base.

CNBC-TV18 poll expects it to be a weak quarter because in the same period last year the company had 22 percent volume growth. It was the first time there was a lockdown and also people had actually stocked up their pantries. On that unfavourable base counter-intuitively, Britannia will report a weak set.

Margins are expected to contract on a higher cost of raw material and impact of packaging as well.

So, all of that put together a 7.50 percent decline in revenues, 22 percent dip in EBITDA, and 24 percent dip in the profit is what the street is working with this time around.

Domestic volumes likely to contract by nearly 8 to 10 percent. This comes on an unfavourable base of 22 percent growth at the same period last year.

Price/mix lead growth will be anywhere between 2 to 3 percent because of higher raw material prices, higher packaging, and inflation in palm oil prices. The company had increased their cost by nearly 2 to 3 percent odd.

(Edited by : Bivekananda Biswas)

First Published:Jul 29, 2021 4:26 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Fox Advertising Invests in Studio, Campus Space for Creators
Fox Advertising Invests in Studio, Campus Space for Creators
Jun 16, 2025
06:07 AM EDT, 06/16/2025 (MT Newswires) -- Fox's (FOX) Fox Advertising said Monday it will invest in The Lighthouse, a studio and campus space for creators to collaborate and develop content. Financial details of the investment were not disclosed. The strategic investment is also expected to support the launch of Fox's new IP development initiative to promote creator-led franchises across...
ING Comments on Euro, Turkey's Lira, Poland's Zloty, Czech Republic's Koruna
ING Comments on Euro, Turkey's Lira, Poland's Zloty, Czech Republic's Koruna
Jun 16, 2025
06:14 AM EDT, 06/16/2025 (MT Newswires) -- The eurozone's dependence on energy price exports should put a curb on EUR/USD upside in ING's view. The bank had already argued before the Israel-Iran conflict began that moves beyond 1.1600 started to look too stretched based on previous peaks of misvaluation. At the time of writing, the short-term fair value is just...
US pharma bets big on China to snap up potential blockbuster drugs
US pharma bets big on China to snap up potential blockbuster drugs
Jun 16, 2025
(Reuters) -U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments. Through June, U.S. drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals...
Copyright 2023-2026 - www.financetom.com All Rights Reserved